CNS Other – 8th: 2018-2022
| Primary Site | Histology | Behavior | Year of Diagnosis |
|---|---|---|---|
| C701, C709, C720-C721, C728-C729 | 8000-8803, 8810-8858, 8860-8900, 8902-8905, 8921, 8932-8934, 8940-8990, 8992, 9000-9016, 9030-9043, 9045-9221, 9230, 9240-9365, 9370-9580, 9582 | 3 | 2018-2022 |
| C722, C724-C725 | 8000-8710, 8712-8790, 8803, 8812-8814, 8816-8824, 8826-8831, 8834-8836, 8841-8842, 8851, 8853, 8855-8857, 8860-8881, 8891-8900, 8902-8905, 8921, 8932-8934, 8940-8990, 8992, 9000-9016, 9030, 9042, 9045-9132, 9135, 9137-9175, 9181-9221, 9230, 9240-9250, 9252-9363, 9365, 9370-9539, 9541, 9550, 9560, 9562-9571, 9582 | 3 | 2018-2022 |
| C723 | 8000-8790, 8803, 8812-8813, 8816-8824, 8826-8828, 8831, 8833-8836, 8841-8842, 8851, 8855-8857, 8860-8881, 8891-8898, 8902-8905, 8932-8934, 8941-8960, 8964-8990, 8992, 9000-9016, 9030, 9041-9043, 9045-9070, 9072-9111, 9121-9132, 9135-9142, 9160-9213, 9221, 9230, 9241-9363, 9365, 9370-9420, 9423-9472, 9474-9493, 9501-9521, 9523, 9531-9539, 9541-9571, 9582 | 3 | 2018-2022 |
| C701, C709, C720-C729 | 8000-9582 | 0, 1 | 2018-2022 |
Notes
**See table above for primary sites and histologies for this schema** C701: Spinal meninges C709: Meninges, NOS C720: Spinal cord C721: Cauda equina C722: Olfactory nerve C723: Optic nerve C724: Acoustic nerve C725: Cranial nerve, NOS C728: Overlapping lesion of brain and central nervous system C729: Nervous system, NOS **Note 1:** **Sources used in the development of this schema** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 72 *Brain and Spinal Cord*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** **Other EOD Schemas with other CNS sites** * All histologies with behavior /0 and /1 are captured in this schema, for behavior /3, see the following schemas for the listed * **GIST**: 8935-8936 * **Orbital Sarcoma (C723)** 8800-8802, 8804-8806, 8810-8811, 8814-8815, 8825, 8830, 8832, 8840, 8850, 8852-8854, 8858, 8890, 8900-8901, 8910, 8912, 8920-8921, 8940, 8963, 9040, 9044, 9071, 9120, 9133, 9150, 9220, 9240, 9364, 9421, 9473, 9500, 9522, 9530, 9540, 9580-9581 * **Soft Tissue Head and Neck (C722, C724-C725)** 8711, 8800-8802, 8810-8811, 8815, 8825, 8832-8833, 8840, 8850, 8852, 8854, 8858-8859, 8890, 8901, 8912, 9040-9041, 9043, 9133, 9136, 9180, 9222, 9251, 9364, 9366-9368, 9540, 9542, 9561, 9580 * **Soft Tissue Rare** * **C701, C709, C720-C721, C728-C729**: 8804-8806, 8859, 8901, 8910-8920, 8930-8931, 8991, 9020, 9044, 9222, 9231, 9366-9368, 9581 * **C722, C724, C725**: 8804-8806, 8910, 8920, 8930-8931, 8991, 9020, 9044, 9231, 9581): * **C723** :8859, 8930-8931, 8991, 9020, 9222, 9231, 9366-9368 **Note 3:** **Summary Stage** * Summary Stage is the only applicable staging system for this site/histology/schema.Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | Yes |
NAACCR #390
dateOfDiagnosis |
None | ||
| Primary Site | Yes |
NAACCR #400
primarySite |
None | ||
| Histology | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | ||
| Behavior | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | ||
| Type of Reporting Source | No |
NAACCR #500
typeOfReportingSource |
None | ||
| Tumor Size Clinical | No |
NAACCR #752
tumorSizeClinical |
None | ||
| Tumor Size Pathological | No |
NAACCR #754
tumorSizePathologic |
None | ||
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 888 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | No |
NAACCR #764
summaryStage2018 |
None | ||
| Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
| Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
| Grade Post Therapy Clin (yc) | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI | |
| Grade Post Therapy Path (yp) | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI | |
| Brain Molecular Markers | 88 | No |
NAACCR #3816
brainMolecularMarkers |
NPCR SEER |
SSDI |
| Chromosome 1p Status | 8 | No |
NAACCR #3801
chromosome1pLossHeterozygosity |
COC SEER |
SSDI |
| Chromosome 19q Status | 8 | No |
NAACCR #3802
chromosome19qLossHeterozygosity |
COC SEER |
SSDI |
| MGMT | 8 | No |
NAACCR #3889
methylationOfO6MGMT |
COC SEER |
SSDI |
| Neoadjuvant Therapy | 9 | No |
NAACCR #1632
neoadjuvantTherapy |
SEER 2021– | SSDI 2021– |
| Neoadjuvant Therapy – Clinical Response | 99 | No |
NAACCR #1633
neoadjuvTherapyClinicalResponse |
SEER 2021– | SSDI 2021– |
| Neoadjuvant Therapy – Treatment Effect | 9 | No |
NAACCR #1634
neoadjuvTherapyTreatmentEffect |
SEER 2021– | SSDI 2021– |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 00722 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
| Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |